Felice Bombaci

1PUBLICATIONS
9CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 15, 2025
Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.

Jorge E Cortes, Timothy P Hughes, Jianxiang Wang

Pageof 1

Frequent Collaborators

1 joint publications

Jorge E Cortes

1 joint publications

Jianxiang Wang

1 joint publications

Yoew-Tee Goh

1 joint publications

Gabriel Etienne

1 joint publications

Ghayas C Issa

1 joint publications

Naoto Takahashi

1 joint publications

Lillian Yau

1 joint publications

Richard A Larson

1 joint publications

Andreas Hochhaus

Frequent Collaborators

1 joint publications

Jorge E Cortes

1 joint publications

Jianxiang Wang

1 joint publications

Yoew-Tee Goh

1 joint publications

Gabriel Etienne

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

810
See more related videos

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

810
See more related videos